Rubicon Organics Inc (ROMJF)
0.2595
+0.01
(+3.80%)
USD |
OTCM |
May 08, 11:31
Rubicon Organics 1 Year Total Returns (Daily): -39.07% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | -39.07% |
May 06, 2024 | -39.07% |
May 03, 2024 | -38.29% |
May 02, 2024 | -30.70% |
May 01, 2024 | -29.32% |
April 30, 2024 | -38.09% |
April 29, 2024 | -38.09% |
April 26, 2024 | -34.40% |
April 25, 2024 | -34.40% |
April 24, 2024 | -36.64% |
April 23, 2024 | -36.45% |
April 22, 2024 | -37.93% |
April 19, 2024 | -36.94% |
April 18, 2024 | -40.58% |
April 17, 2024 | -40.78% |
April 16, 2024 | -37.60% |
April 15, 2024 | -39.18% |
April 12, 2024 | -38.23% |
April 11, 2024 | -38.89% |
April 10, 2024 | -37.02% |
April 09, 2024 | -36.54% |
April 08, 2024 | -35.44% |
April 05, 2024 | -33.47% |
April 04, 2024 | -31.44% |
April 03, 2024 | -34.08% |
Date | Value |
---|---|
April 02, 2024 | -32.32% |
April 01, 2024 | -32.32% |
March 28, 2024 | -34.96% |
March 27, 2024 | -35.96% |
March 26, 2024 | -26.36% |
March 25, 2024 | -34.26% |
March 22, 2024 | -37.34% |
March 21, 2024 | -38.15% |
March 20, 2024 | -38.15% |
March 19, 2024 | -43.02% |
March 18, 2024 | -46.53% |
March 15, 2024 | -43.63% |
March 14, 2024 | -43.56% |
March 13, 2024 | -44.85% |
March 12, 2024 | -40.42% |
March 11, 2024 | -37.37% |
March 08, 2024 | -40.08% |
March 07, 2024 | -40.08% |
March 06, 2024 | -41.56% |
March 05, 2024 | -40.78% |
March 04, 2024 | -37.38% |
March 01, 2024 | -35.56% |
February 29, 2024 | -40.78% |
February 28, 2024 | -36.83% |
February 27, 2024 | -34.73% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.18%
Minimum
Nov 03 2022
181.8%
Maximum
Dec 10 2020
-18.83%
Average
-36.86%
Median
Feb 28 2020
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 5.70% |
Aurinia Pharmaceuticals Inc | -55.71% |
Edesa Biotech Inc | -39.08% |
Lexaria Bioscience Corp | 161.8% |
Xenon Pharmaceuticals Inc | 2.40% |